title: Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations.
abstract: The application of cationic liposome reagents has advanced DNA and mRNA transfection research in vitro, and data are accumulating which show their utility for in vivo gene transfer. However, chemical structure-activity data leading to a better mechanistic understanding of their biological activity is still limited. Most of the cationic lipid reagents in use today for this application are formulated as liposomes containing two lipid species, a cationic amphiphile and a neutral phospholipid, typically dioleoylphosphatidylethanolamine (DOPE). The studies reported here examine the effects of some systematic chemical structural changes in both of these lipid components. Cationic and neutral phospholipids were formulated together as large multilamellar vesicles (MLV) or small sonicated unilamellar vesicles (SUV) in water, and each formulation was assayed quantitatively in 96-well microtiter plates under 64 different assay conditions using COS.7 cells and an RSV-beta-galactosidase expression plasmid. The cationic lipid molecules used for these studies were derived from a novel series of 2,3-dialkyloxypropyl quaternary ammonium compounds containing a hydroxyalkyl moiety on the quaternary amine. A homologous series of dioleylalkyl (C18:1) compounds containing increasing hydroxyalkyl chain lengths on the quaternary amine were synthesized, formulated with 50 mol % DOPE, and assayed for transfection activity. The order of efficacy was ethyl > propyl > butyl > pentyl > 2,3-dioleyloxypropyl-1-trimethyl ammonium bromide (DOTMA). DOTMA, which is commercially available under the trademark Lipofectin Reagent, lacks a hydroxyalkyl moiety on the quaternary amine. A homologous series of hydroxyethyl quaternary ammonium derivatives with different alkyl chain substitutions were synthesized, formulated with 50 mol % DOPE, and assayed in the transfection assay. The order of transfection efficacy was dimyristyl (di-C14:0) > dioleyl (di-C18:1) > dipalmityl (di-C16:0) > disteryl (di-C18:0). The addition of 100 microM chloroquine in the transfection experiment enhanced the activity of the dioleyl compound by 4-fold and decreased the activity of the dimyristyl compound by 70%. For each of the compounds and formulations examined in this report, large multilamellar vesicles (MLV; diameter 300-700 nm) were more active than small unilamellar vesicles (SUV; diameter 50-100 nm). The neutral phospholipid requirements for transfection activity in COS.7 cells with these cationic lipid molecules were examined.(ABSTRACT TRUNCATED AT 400 WORDS)
authors.affiliation: VICAL Inc., San Diego, California 92121.
authors.forename: J H
authors.initials: JH
authors.lastname: Felgner
authors.forename: R
authors.initials: R
authors.lastname: Kumar
authors.forename: C N
authors.initials: CN
authors.lastname: Sridhar
authors.forename: C J
authors.initials: CJ
authors.lastname: Wheeler
authors.forename: Y J
authors.initials: YJ
authors.lastname: Tsai
authors.forename: R
authors.initials: R
authors.lastname: Border
authors.forename: P
authors.initials: P
authors.lastname: Ramsey
authors.forename: M
authors.initials: M
authors.lastname: Martin
authors.forename: P L
authors.initials: PL
authors.lastname: Felgner
mesh_terms: D000818:Animals; D002460:Cell Line; D002522:Chlorocebus aethiops; D004337:Drug Carriers; D015870:Gene Expression; D007668:Kidney; D008081:Liposomes; D008968:Molecular Conformation; D010714:Phosphatidylethanolamines; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000378:metabolism; D013329:Structure-Activity Relationship; D014162:Transfection / Q000379:methods*; D001616:beta-Galactosidase / Q000096:biosynthesis* / Q000378:metabolism
chemical_list: D004337:Drug Carriers; D008081:Liposomes; D010714:Phosphatidylethanolamines; D011994:Recombinant Proteins; C020888:1,2-dielaidoylphosphatidylethanolamine; D001616:beta-Galactosidase